Nathan D. Jorgensen - 06 Nov 2023 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Chief Financial Officer
Signature
/s/ Katie Kazem, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
06 Nov 2023
Net transactions value
-$1,518
Form type
4
Filing time
08 Nov 2023, 16:12:06 UTC
Previous filing
06 Sep 2023
Next filing
31 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VOR Common Stock Tax liability $1,518 -834 -0.57% $1.82 145,647 06 Nov 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.